Wenxiu Lv, Wenxiu Lv, Tianping Chen, Shen Wang, Chun Li, Bo Zhang, . . . Hongjun Liu. (2023). Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia. Frontiers Media S.A..
Chicago Style (17th ed.) CitationWenxiu Lv, et al. Feasibility of High-throughput Drug Sensitivity Screening (HDS)-guided Treatment for Children with Refractory or Relapsed Acute Myeloid Leukemia. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationWenxiu Lv, et al. Feasibility of High-throughput Drug Sensitivity Screening (HDS)-guided Treatment for Children with Refractory or Relapsed Acute Myeloid Leukemia. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.